Georgios N. Tsaousis
Athens, ESYE31 15344, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.
Journal: Journal of medical genetics
Published: January 13, 2026
Evaluation of the 1021-HRD assay compared to established HRD testing platforms in ovarian cancer.
Journal: Translational oncology
Published: May 26, 2025
Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use.
Journal: International journal of molecular sciences
Published: April 23, 2025
The Clinical and Genetic Landscape of Hereditary Cancer: Experience from a Single Clinical Diagnostic Laboratory.
Journal: Cancer genomics & proteomics
Published: June 26, 2024
Polygenic Risk Score (PRS) Combined with NGS Panel Testing Increases Accuracy in Hereditary Breast Cancer Risk Estimation.
Journal: Diagnostics (Basel, Switzerland)
Published: June 11, 2024
Microsatellite Instability Is Insufficiently Used as a Biomarker for Lynch Syndrome Testing in Clinical Practice.
Journal: JCO precision oncology
Published: January 25, 2024
Germline Co-deletion of CDKN2A and CDKN2B Genes in Pleomorphic Xanthoastrocytoma: Case Report.
Journal: In vivo (Athens, Greece)
Published: January 19, 2024
Digging into the NGS Information from a Large-Scale South European Population with Metastatic/Unresectable Pancreatic Ductal Adenocarcinoma: A Real-World Genomic Depiction.
Journal: Cancers
Published: October 05, 2023
Concordance between Three Homologous Recombination Deficiency (HRD) Assays in Patients with High-Grade Epithelial Ovarian Cancer.
Journal: Cancers
Published: September 27, 2023
Last Updated: 09/26/2026